Recursion Pharmaceuticals Inc vs Stanley Black & Decker, Inc. — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while Stanley Black & Decker, Inc. trades at $87.62 (market cap $13.60B). The key difference: Stanley Black & Decker, Inc. is far larger — about 8.9× Recursion Pharmaceuticals Inc's market cap, and Stanley Black & Decker, Inc. pays a 3.79% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | SWK | |
|---|---|---|
Market Cap | $1.53B | $13.60B |
Sector | Health | — |
52-Week High | $6.79 | $94.12 |
52-Week Low | $2.84 | $62.12 |
Enterprise Value | $946.50M | $19.77B |
Dividend Yield | — | 3.79% |
Trailing returns across standard periods
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Stanley Black & Decker Inc is a manufacturer of hand and power tools. The company operates three business segments: tools and storage, security, and industrial. Tools and storage, the largest segment by revenue, sells hand tools and power tools to professional end-users, distributors, retail consumers, and industrial customers. Security installs electronic security systems and provides electronic security services including alarm monitoring and video surveillance. Industrial sells engineered fastening products such as stud-welding systems, blind inserts and tools, and engineered plastic and mechanical fasteners. The largest end market is the United States of America.
Read more on SWK →